M
Mark Walker
Researcher at University of Ottawa
Publications - 690
Citations - 63950
Mark Walker is an academic researcher from University of Ottawa. The author has contributed to research in topics: Population & Pregnancy. The author has an hindex of 97, co-authored 622 publications receiving 58554 citations. Previous affiliations of Mark Walker include Newcastle University & Queen's University.
Papers
More filters
Journal ArticleDOI
A survey of preconceptional folic acid use in a group of Canadian women.
TL;DR: Ethnic background is an independent predictor of periconceptional folic acid use among Canadian women in a multi-ethnic, urban setting and is more common among women of Jewish descent.
Journal ArticleDOI
The Association Between Sleep Duration, Insulin Sensitivity, and β-Cell Function: The EGIR-RISC Study
Femke Rutters,Hervé Besson,Mark Walker,Andrea Mari,Thomas Konrad,Peter M. Nilsson,Beverley Balkau,Jacqueline M. Dekker +7 more
TL;DR: Sleep duration is associated with insulin sensitivity and β-cell function in a sex-specific manner in clinically healthy people.
Journal ArticleDOI
The role of maternal homocysteine concentration in placenta-mediated complications: findings from the Ottawa and Kingston birth cohort.
Shazia H Chaudhry,Shazia H Chaudhry,Monica Taljaard,Monica Taljaard,Amanda J. MacFarlane,Amanda J. MacFarlane,Laura Gaudet,Laura Gaudet,Graeme N. Smith,Graeme N. Smith,Marc A. Rodger,Marc A. Rodger,Ruth Rennicks White,Mark Walker,Mark Walker,Shi Wu Wen,Shi Wu Wen +16 more
TL;DR: An independent effect of early to mid-pregnancy elevated maternal homocysteine on placenta-mediated pregnancy complications is suggested, suggesting some potential for modifying effects of the MTHFR 677C>T genotype and high-risk pregnancy.
Journal ArticleDOI
(Z)-3-fluorophosphoenolpyruvate as a pseudosubstrate of EPSP synthase : enzymatic synthesis of a stable fluoro analog of the calalytic intermediate
Journal ArticleDOI
Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI DIRECT study
Agata Wesolowska-Andersen,Caroline Brorsson,Roberto Bizzotto,Andrea Mari,Andrea Tura,Robert W. Koivula,Anubha Mahajan,Ana Viñuela,Juan Fernandez Tajes,Sapna Sharma,Mark Haid,Cornelia Prehn,Anna Artati,Mun-Gwan Hong,PB Musholt,Azra Kurbasic,Federico De Masi,K. Tsirigos,Helle Krogh Pedersen,Valborg Gudmundsdottir,Cecilia Engel Thomas,Karina Banasik,Angus G. Jones,Gwen Kennedy,Jimmy D. Bell,Louise Thomas,G Frost,Henrik Thomsen,Kristine H. Allin,T. Hansen,Henrik Vestergaard,Torben Hansen,Femke Rutters,Petra J. M. Elders,L. t’Hart,Amélie Bonnefond,Mickaël Canouil,Soren Brage,Tarja Kokkola,Alison Heggie,Donna McEvoy,Andrew T. Hattersley,Timothy J. McDonald,Harriet Teare,Martin Ridderstråle,Mark Walker,I.M. Forgie,Giuseppe N. Giordano,Philippe Froguel,Imre Pavo,Hartmut Ruetten,Oluf Pedersen,Emmanouil T. Dermitzakis,Paul W. Franks,Jochen M. Schwenk,Jerzy Adamski,E W Pearson,Mark I. McCarthy,Søren Brunak +58 more
TL;DR: In this article , the authors apply a soft-clustering (archetype) method to characterize newly diagnosed Type 2 diabetes (T2D) based on 32 clinical variables and investigate the associations with glycemic deterioration, genetic risk scores, circulating omics biomarkers, and phenotypic stability over 36 months.